Business
Aurora Cannabis Receives EU GMP Certification for its Aurora River Facility
Aurora Cannabis Receives EU GMP Certification for its Aurora River Facility Canada...
About this update from Aurora Cannabis Inc.
[{"type":"text","content":"\n\n\n\nAurora Cannabis Receives EU GMP Certification for its Aurora River Facility\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nEDMONTON, Feb. 3, 2020\n\n\n\nAchievement increases total production capacity available to serve international medical markets by 230% Brings Aurora's total number of EU GMP certified Canadian production facilities to 3 Pharmacies in Germany have been instructed to resume sales of Aurora's suite of medical cannabis following temporary pause NYSE | TSX : ACB \n EDMONTON, Feb. 3, 2020 /CNW/ - Aurora Cannabis Inc. (\"Aurora\" or the \"Company\") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, announced today its Aurora River production facility, located in Bradford, Ontario, has received European Union Good Manufacturing Practice (\"EU GMP\") certification. EU GMP certification is granted to companies whose production facilities demonstrate a high degree of quality and consistency in their manufacturing procedures and is a requirement for the export of medical cannabis products into most European markets. \n\n \n \n\n \nIn addition, Aurora is pleased to announce it has received all necessary approvals from local regulators in Germany for sales of its medical cannabis products, following a temporary sales suspension on certain products in December 2019. Aurora will fulfill existing sales orders from inventory currently held in Germany, ensuring local patients will have immediate access to medicine from their preferred pharmacy. \n\"Aurora is leading the development of medical markets across Europe and around the world,\" said Terry Booth, CEO of Aurora. \"The EU GMP certification of our River facility further validates our strategy focused on purpose-built facilities, designed and constructed exclusively for the production of high-quality, pharmaceutical grade cannabis. I congratulate our team on successfully working with regulators and licensing bodies to ensure Aurora's facilities and products are in accordance with local and international standards that will allow for greater acc...